These include an increase in inflammatory cytokines that activates bone-resorbing osteoclasts, mutations in the FTO gene, increased osteoblast senescence caused by obesity, and an increased production of bone marrow fat cells at the expense of bone-forming osteoblasts [34]. The gene discussed is FTO; the disease is obesity due to melanocortin 4 receptor deficiency.